Across TCGA pan-cancer cohorts, LINC02567 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LINC02567’s most consistent transcriptional readouts.
The strongest signal is observed in thyroid carcinoma (THCA), where LINC02567 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02567 is over-expressed in tumor.
THCA and LUSC are the cancer types where LINC02567 tumor–normal differential expression is most reproducible.